Stocks Rise Pre-Bell After Nasdaq Reaches New Record High
MT newswire2026/10/06 11:5607:56 AM EDT, 10/06/2026 (MT Newswires) -- US equity futures were tracking in the green on Tuesday following gains in the previous session, when the tech-heavy Nasdaq reached a record closing high. The S&P 500 rose 0.2%, the Dow Jones Industrial Average increased 0.5%, and the Nasdaq 100 added 0.3% in premarket activity. The indexes finished Monday trading strong, with the Nasdaq Composite hitting a new peak. Shares of major companies in the artificial intelligence trade were trending upwards pre-bell, including SpaceX (SPCX), Nvidia (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD) and Qualcomm (QCOM). Microsoft (MSFT), Meta Platforms (META) and Amazon (AMZN) were also up early Tuesday. Treasury yields were down, with the two-year rate retreating 2.1 basis points to 4.81% and the 10-year rate falling 3.4 basis points to 5.28%. The latter reached its highest level since April 2002 on Monday, according to CNBC. The Federal Reserve is scheduled to post minutes from its September policy meeting on Wednesday, which will be assessed for fresh insight into the central bank's monetary policy. At that meeting, the central bank raised interest rates by 25 basis points, its first hike in just over three years, to combat inflation that has run persistently above its 2% target. Markets are currently pricing in a 78% probability that the Fed will keep its benchmark rate steady this month, with the remaining odds in favor of a 25-basis-point hike, according to the CME FedWatch tool. Fed Vice Chair for Supervision Michelle Bowman is scheduled to speak at 10:45 am ET. New York Fed President John Williams, Kansas City Fed President Jeffrey Schmid and Dallas Fed President Lorie Logan are also slated to speak on Tuesday. Tuesday's thin economic calendar has the international trade in goods and services report for August at 8:30 am. West Texas Intermediate crude oil declined 1.9% to $87.76 a barrel, while Brent dropped 1.8% to $98.49. Yemen's government forces said on social media that they've reclaimed control of the strategic por
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
Crypto prices
More
